Jan de Jong

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

P. Charles, Ruud J.T. Smeenk, Jan de Jong et al. · Arthritis & Rheumatism · 2000 · 530 citations

From student to teacher: reducing practice shock and early dropout in the teaching profession

Karel M. Stokking, Frieda Leenders, Jan de Jong et al. · European Journal of Teacher Education · 2003 · 244 citations

Teacher Education, Performance Studies, Teaching +13

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

Anas Younes, Joshua Brody, Cecilia Carpio et al. · The Lancet Haematology · 2019 · 194 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +8

The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD

Hanneke Beaumont, Roel J. Bennink, Jan de Jong et al. · Gut · 2009 · 191 citations · Full text

Narrative abilities, memory and attention in children with a specific language impairment

Iris Duinmeijer, Jan de Jong, Annette Scheper · International Journal of Language & Communication Disorders · 2012 · 165 citations